Synoglim MV 2.3 Tablet SR
Marketer
Synodic Lifesciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Synoglim MV 2.3 Tablet SR
Glimepiride and Metformin extended-release tablets are antidiabetic medications used in combination to manage type 2 diabetes in adults. This treatment helps regulate blood glucose levels. These tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is necessary for treatment. Regular meals and carrying a fast-acting glucose source are recommended. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Synoglim MV 2.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Synoglim MV 2.3 Tablet SR:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Synoglim MV 2.3 Tablet SR on an empty stomach.
Common Side effects of Synoglim MV 2.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Synoglim MV 2.3 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Synoglim MV 2.3 Tablet SR on an empty stomach.
How Synoglim MV 2.3 Tablet SR works:
Synoglim MV 2.3 extended-release tablets contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Synoglim MV 2.3 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Synoglim MV 2.3 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Synoglim MV 2.3 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by abnormally high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney impairment should likely avoid Synoglim MV 2.3 Tablet SR; its use is considered unsafe. Those with severe kidney disease should definitely not take Synoglim MV 2.3 Tablet SR. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Synoglim MV 2.3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation should involve a reduced Synoglim MV 2.3 Tablet SR dosage; however, it's contraindicated in those with severe liver disease.
What if you forget to take Synoglim MV 2.3 Tablet SR :
Should you forget to take a Synoglim MV 2.3 Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Synoglim MV 2.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


